Multi-institutional validation survey on Belong.life's conversational artificial intelligence (AI) oncology mentor, "Dave. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study. This is an ASCO Meeting Abstract ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果